UBS Group »

Pmv Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Pmv Pharmaceuticals (PMVP) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Pmv Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pmv Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pmv Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $396k 128k 3.10
2023-09-30 $882k 144k 6.14
2023-06-30 $612k 98k 6.26
2023-03-31 $428k 90k 4.77
2022-12-31 $2.5M 284k 8.70
2022-09-30 $1.4M 120k 11.90
2022-06-30 $5.0M 350k 14.25
2022-03-31 $4.0M 189k 20.94
2021-12-31 $3.0M 129k 23.09
2021-09-30 $2.9M 96k 29.81
2021-06-30 $38k 1.1k 35.03
2021-03-31 $426k 13k 32.92
2020-12-31 $155k 2.5k 61.36
2020-09-30 $20k 571 35.03